¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Secondary malignant neoplasm of other specified sites"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • malignant melanoma
    ¾Ç¼ºÈæ»öÁ¾
  • malignant mesothelioma
    ¾Ç¼ºÁßÇÇÁ¾
  • malignant myopia
    ¾Ç¼º±Ù½Ã
  • malignant smallpox
    ¾Ç¼º¸¶¸¶
  • malignant teratoma
    ¾Ç¼º±âÇüÁ¾
  • malignant transformation
    ¾Ç¼ºÀüȯ
  • malignant tumor
    ¾Ç¼ºÁ¾¾ç
  • neuroleptic malignant syndrome
    ½Å°æÀÌ¿ÏÁ¦¾Ç¼ºÁõÈıº
  • secondary
    1. ÀÌÂ÷- 2. Á¦2- 3. ¼Ó¹ß-
  • secondary amenorrhea
    ¼Ó¹ß¹«¿ù°æ
  • secondary aqueous
    Àç»ý¹æ¼ö, ÀÌÂ÷¹æ¼ö
  • secondary attack rate
    ÀÌÂ÷¹ßº´·ü
  • secondary biliary cirrhosis
    ¼Ó¹ß¾µ°³°ü°£°æÈ­(Áõ)
  • secondary cardiomyopathy
    ÀÌÂ÷½ÉÀå±ÙÀ°º´(Áõ), ÀÌÂ÷½É±Ùº´(Áõ)
  • secondary constriction
    ÀÌÂ÷ÇùÂø
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • secondary suture
    ÀÌÂ÷ºÀÇÕ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • malignant acanthosis nigricans
    ¾Ç¼ºÈæ»ö°¡½Ã¼¼Æ÷Áõ
  • malignant melanoma
    ¾Ç¼ºÈæ»öÁ¾
  • malignant myopia
    (¢¡degenerative myopia) º¯¼º±Ù½Ã
  • malignant smallpox
    ¾Ç¼º¸¶¸¶
  • malignant teratoma
    ¾Ç¼º±âÇüÁ¾
  • malignant transformation
    ¾Ç¼º¼¼Æ÷Àüȯ
  • malignant tumor
    ¾Ç¼ºÁ¾¾ç
  • malignant chondroid syringoma
    ¾Ç¼º¿¬°ñ¶¡°üÁ¾
  • malignant mast mast reticulosis
    ¾Ç¼ººñ¸¸¼¼Æ÷±×¹°Áõ, ¾Ç¼ººñ¸¸¼¼Æ÷¼¼¸ÁÁõ
  • neuroleptic malignant syndrome
    Ç×Á¤½Åº´¾à¹°¾Ç¼ºÁõÈıº
  • secondary amenorrhea
    ÀÌÂ÷¹«¿ù°æ, ¼Ó¹ß¹«¿ù°æ
  • secondary aqueous
    Àç»ý¹æ¼ö, ÀÌÂ÷¹æ¼ö
  • secondary cardiomyopathy
    ÀÌÂ÷½ÉÀå±ÙÀ°º´Áõ
  • secondary constriction
    ÀÌÂ÷ÇùÂø
  • secondary contact
    ÀÌÂ÷Á¢ÃË
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • borderline malignant epithelial ovarian neoplasms
    °æ°è¼º »óÇǼº ³­¼ÒÁ¾¾ç
  • fibrous histiocytoma,malignant
    ¾Ç¼º¡­ (äÂàõ¡­)
  • granuloma, malignant
    ¾Ç¼ºÀ°¾ÆÁ¾
  • histiocytoma,malignant fibrous
    Á¶Á÷±¸Á¾, ¾Ç¼º ¼¶À¯¼º
  • histiocytosis,malignant
    ¾Ç¼º
  • hypertension,malignant
    ¾Ç¼º(äÂàõ)
  • jaw,nonodontogenic malignant tumor
    ºñÄ¡¾Æ¼º ¾Ç¼ºÁ¾¾ç (¡­ äÂàõðþåË)
  • lues maligna => malignant syphilis
    ¾Ç¼º(äÂàõ)¸Åµ¶
  • malignant
    ¾Ç¼º(ç÷àõ)ÀÇ.
  • malignant
    ¾Ç¼º(ç÷àõ)ÀÇ
  • malignant
    ¾Ç¼ºÀÇ, (ºÏ) ¾Ç¼ºÀÇ
  • malignant Spitz nevus
    ¾Ç¼º ½ºÇÇÃ÷ ¸ð¹Ý
  • malignant acanthosis nigricans
    ¾Ç¼º Èæ»ö ±Ø¼¼Æ÷Áõ
  • malignant adenoma
    ¾Ç¼º¼±Á¾(ç÷àõàÍðþ).
  • malignant adenoma
    ¾Ç¼º¼±Á¾(¡­àÍðþ)
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • Secondary ossification center
    ÀÌÂ÷»À¹ß»ýÁß½É
    [¿¾ ¿ë¾î] ÀÌÂ÷°ñÈ­Áß½É
  • Secondary ossification center [Epiphyseal ossification cente
    ÀÌÂ÷»À¹ß»ýÁ᫐ [»À³¡»À¹ß»ýÁß½É]
    [¿¾ ¿ë¾î] ÀÌÂ÷°ñÈ­Áß½É
  • Secondary bone trabecula
    ÀÌÂ÷»ÀÀܱâµÕ
    [¿¾ ¿ë¾î] ÀÌÂ÷°ñ¼ÒÁÖ
  • Secondary dentin
    ÀÌÂ÷»ó¾ÆÁú
    [¿¾ ¿ë¾î] ÀÌÂ÷»ó¾ÆÁú
  • Secondary nodule
    ÀÌÂ÷¼ÒÀý
    [¿¾ ¿ë¾î] ÀÌÂ÷¼ÒÀý
  • Secondary villus
    ÀÌÂ÷À¶¸ð
    [¿¾ ¿ë¾î] ÀÌÂ÷À¶¸ð
  • Secondary pregnancy
    ÀÌÂ÷ÀÓ½Å
    [¿¾ ¿ë¾î] ÀÌÂ÷ÀÓ½Å
  • Secondary spermatocyte
    ÀÌÂ÷Á¤¸ð¼¼Æ÷
    [¿¾ ¿ë¾î] ÀÌÂ÷Á¤¸ð¼¼Æ÷
  • Secondary spermatocyte
    ÀÌÂ÷Á¤¸ð¼¼Æ÷
    [¿¾ ¿ë¾î] Á¦ÀÌÁ¤¸ð¼¼Æ÷
  • Secondary nasal septum
    ÀÌÂ÷ÄÚÁß°Ý
    [¿¾ ¿ë¾î] ÀÌÂ÷ºñÁß°Ý
  • Secondary hair follicle
    ÀÌÂ÷ÅÐÁÖ¸Ó´Ï
    [¿¾ ¿ë¾î] ÀÌÂ÷¸ð³¶
  • Secondary sponge bone
    ÀÌÂ÷ÇØ¸é»À
    [¿¾ ¿ë¾î] ÀÌÂ÷ÇØ¸é°ñ
  • Secondary pulmonary lobule
    ÀÌÂ÷ÇãÆÄ¼Ò¿±
    [¿¾ ¿ë¾î] ÀÌÂ÷Æó¼Ò¿±
  • Palatine process [Secondary palate]
    ÀÔõÀåµ¹±â [ÀÌÂ÷ÀÔõÀå]
    [¿¾ ¿ë¾î] ±¸°³µ¹±â(ÀÌÂ÷±¸°³)
  • Lamellar membranous bone [Secondary membranous bone]
    ÃþÆÇ¸·»À [ÀÌÂ÷¸·»À]
    [¿¾ ¿ë¾î] ÀÌÂ÷¸·¼º°ñ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • secondary hydration shell
    ÀÌÂ÷(ì£ó­) ¼öÈ­ â©ûù ²®Áú
  • secondary ionization
    ÀÌÂ÷(ì£ó­) ÀÌ¿ÂÈ­(ûù)
  • secondary ion mass spectrometry
    ÀÌÂ÷ ÀÌ¿ÂÁú·®ºÐ±¤¹ý(ì£ó­òõÕáÝÂÎÃÛö)
  • secondary isotope effect
    ÀÌÂ÷ µ¿À§¿ø¼ÒÈ¿°ú(ì£ó­ÔÒêÈêªáÈüùÍý)
  • secondary lysosome
    ÀÌÂ÷(ì£ó­) ¶óÀ̼ҼØ
  • secondary malnutrition
    ÀÌÂ÷ ¿µ¾ç½ÇÁ¶(ì£ó­ç½å×ã÷ðà)
  • secondary messenger
    ÀÌÂ÷ Àü·É (ì£ó­îîÖµ)
  • secondary metabolite
    ÀÌÂ÷ ´ë»ç¹°(ì£ó­ÓÛÞóÚª)
  • secondary plant constituent
    ÀÌÂ÷ ½Ä¹°¼ººÐ(ì£ó­ãÕÚªà÷ÝÂ)
  • secondary plot
    ÀÌÂ÷(ì£ó­) Ç÷Ô
  • secondary protein derivative
    ÀÌÂ÷ ´Ü¹éÁúÀ¯µµÃ¼(ì£ó­Ó±ÛÜòõë¯Óôô÷)
  • secondary solvent
    ÀÌÂ÷ ¿ë¸Å(ì£ó­éÁØÚ)
  • secondary standard
    ÀÌÂ÷ Ç¥ÁØ(ì£ó­øöñÞ)
  • secondary structure
    ÀÌÂ÷ ±¸Á¶(ì£ó­Ï°ðã)
  • super-secondary structure
    ÃÊÀÌÂ÷ ±¸Á¶(õ±ì£ó­Ï°ðã)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 6 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • secondary ossification center
    ÀÌÂ÷°ñÈ­Áß½É
  • secondary pneumonia
    ¼Ó¹ß¼ºÆó·Å
  • secondary sex characteristic
    ÀÌÂ÷¼ºÂ¡
  • secondary sterility
    ¼Ó¹ßºÒÀÓ
  • secondary tuberculosis
    ÀÌÂ÷¼º°áÇÙ
  • secondary X-ray
    ÀÌÂ÷X¼±
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
MRN malignant renal neoplasm
SMN second malignant neoplasm; stathmin
ad add [Lat. adde] let there be added [up to a specified amount] [Lat. addetur]; axiodistal; right ear ...
NES not elsewhere specified
NOS network operating system; nitric oxide synthetase; non-organ-specific; not on staff; not otherwise s...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
DRO Differential Reinforcement of Other Behaviour
MOTT Mycobacteria Other Than Tuberculosis
OND Other Neurological Diseases
SO significant other
AOD and other drug
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • malignant carcinoid tumor
    ¾Ç¼º Ä«¸£½Ã³ëÀ̵å Á¾¾ç
  • malignant degeneration
    ¾Ç¼ºÈ­
  • malignant external otitiis
    ¾Ç¼º ¿ÜÀÌ¿°
    ´ç´¢º´ ȯÀÚ³ª ¿©·¯ °¡Áö ¿øÀÎÀ¸·Î ¸é¿ª Àå¾Ö ȯÀڵ鿡¼­ ¿ÜÀ̵µ¿°ÀÌ ÁøÇàµÇ¾î µÎ°³ÀúÀÇ °ñ¼ö¿°¿¡ À̸£°Ô µÇ´Âµ¥ À̸¦ ¾Ç¼º ¿ÜÀÌ¿°À̶ó ÇÑ´Ù. ¿øÀαÕÀº Pseudomonas aeruginosaÀÌ¸ç ¿ÜÀ̵µÀÇ ¹Ù´Ú ºÎÀ§¿¡¼­ ±â½ÃÇÏ¿© Áߵΰ³Àú¿Í clivus, ½ÉÁö¾î´Â ¹Ý´ëÂÊÀÇ µÎ°³Àú¿¡ À̸£±âµµ ÇÑ´Ù. ȯÀÚµéÀº ´ë°³ ¾ÇÃë°¡ ³ª´Â ÀÌ·ç¿Í ÇÔ²² ¿ÜÀ̵µ¿¡´Â À°¾ÆÁ¶Á÷ÀÌ °üÂûµÇ°í ±íÀº ºÎÀ§ÀÇ ÀÌÅëÀ» È£¼ÒÇÑ´Ù. Áø´ÜÀº CT ÃÔ¿µÀ̳ª, ¹æ»ç¼± µ¿À§¿ø¼Ò¸¦ ÀÌ¿ëÇÑ °ñ ÁÖ»ç
  • malignant granuloma
    ¾Ç¼º À°¾ÆÁ¾
    ¾Ç¼º ¸²ÇÁÁ¾, º£°Ô³Ê À°¾ÆÁ¾°ú ´Ù¸£Áö¸¸ ±× º´ ÀÚü°¡ ¹àÇôÁöÁö ¾Ê¾Æ Á¾¾ç ¿©ºÎ Á¶Â÷µµ È®½ÇÇÏÁö ¾ÊÀºµ¥, ±«»ç¼º º´º¯ÀÌ ³Ê¹« °­ÇϹǷΠº´¸®Á¶Á÷ÇÐÀû °Ë»öµµ °ï¶õÇÏ´Ù. Àü½Å¼º ÀüÀÌ´Â ÀûÀ¸³ª ±¹¼ÒÀû ±«»ç ÁøÇàÀÌ ´ë´ÜÈ÷ ºü¸£°í ¼¼±Õ °¨¿°À» ÀÏÀ¸Å°±â ½¬¿ì¸ç ÆÐÇ÷Áõ°ú À¯»çÇÑ °£Çæ ¿­°ú °í¿­ÀÌ ÀϾ Àü½ÅÀÌ ¼è¾àÇØÁö°í ¿¹Èİ¡ ³ª»Ú´Ù.
  • malignant hemocytoblastoma
    ¾Ç¼º Ç÷±¸¸ð¼¼Æ÷Á¾
  • malignant hyperthermia
    ¾Ç¼º °í¿­Áõ, ¾Ç¼º °í¿­
    ¸¶Ãë Áß¿¡ °©ÀÚ±â °í¿­À» ³»°í »ç¸Á·üÀÌ ±ØÈ÷ ³ôÀº ÁõÈıº¿¡ ´ëÇÏ¿© À̸§ÀÌ ºÙ¿©Áø °ÍÀÌ´Ù. Áõ»óÀº È£ÈíÀ̳ª ¸Æ¹ÚÀÌ »¡¶óÁö°í ü¿ÂÀº 5ºÐ¿¡ 1¡É Á¤µµÀÇ ¼Óµµ·Î 42¡É¿¡³ª ´ÞÇÑ´Ù. µ¿½Ã¿¡ ±ÙÀÇ °æÁ÷À̳ª °ú±äÀåÀÌ »ý±â°í ´ë»ç¼º ¹× È£Èí¼º »êÁõ, °íÄ®·ýÇ÷ÁõÀÌ ³ªÅ¸³­´Ù. ±Ù°æÁ÷¼º À§Ãà, À¯ÀüÀÚ ÀÎÀÚ
  • malignant hyperthermia syndrome
    ¾Ç¼º °í¿­ ÁõÈıº
  • malignant lesion
    ¾Ç¼º º´¼Ò
  • malignant melanoma
    ¾Ç¼º Èæ»öÁ¾
    1. ¿ÜÀ½¿¡ »ý±â´Â °¡Àå Áß¿äÇÑ º´º¯ÀÎ Á¾¾çÀÇ ÀÏÁ¾À¸·Î ¿ÜÀ½ÀÇ ¾Ç¼º Èæ»öÁ¾Àº µå¹°°í, ¿©¼º¿¡¼­ °üÂûµÇ´Â Èæ»öÁ¾ÀÇ 2%°¡ ¿ÜÀ½¿¡¼­ ¹ß»ýÇÑ´Ù. 2. »ö¼Ò ¼¼Æ÷¿¡ »ý±ä ¾Ç¼º Á¾¾ç. 3. Ç¥ÇǼº Èæ»ö±¸¿Í ±× Àü±¸Ã¼·ÎºÎÅÍ ¹ß»ýÇÏ´Â ´ë´ÜÈ÷ ¾Ç¼ºÀÎ Á¾¾çÀÌ´Ù. ¸ðµç ¾Ç¼º Á¾¾ç Áß 1%°¡ ¾Ç¼º Èæ»öÁ¾ÀÌ´Ù. ÀÌÁß 90%´Â ¿ÜÇÇ¿¡ ³ªÅ¸³ª°í 10%´Â ÇǺΠ¿Ü¿¡ ³ªÅ¸³­´Ù. ¸ðµç ¾Ç¼º Èæ»öÁ¾ Áß 1%´Â ±¸°­ ³»¿¡¼­ ¹ß»ýÇÑ´Ù. ¹ß»ýÀ²ÀÌ Áõ°¡µÇ´Â °Íó·³ º¸ÀÌ´Â ÀÌ·± Á¾¾çÀÇ Æ¯È÷ ³ª»Û Á¡Àº ¸²ÇÁ ¼øÈ¯°ú Ç÷¾× ¼øÈ¯À» ÅëÇØ ºü¸£°Ô ÀüÀ̵Ǵ °ÍÀÌ´Ù.
  • malignant mesenchymoma
    ¾Ç¼º ³»¹è¿±Á¾
  • malignant myopia
    ¾Ç¼º ±Ù½Ã
    Ã༺ ±Ù½Ã·Î¼­ ¾ÈÃàÀåÀÌ ±¼Àý·Â¿¡ ºñÇØ ³Ê¹« ±æ¾î ÆòÇà ±¤¼±ÀÌ ¸Á¸· ¾Õ¿¡ ÃÊÁ¡À» ¸ÎÀ¸¹Ç·Î ¼±¸íÇÏÁö ¾ÊÀº »óÀ» ¸Î°Ô µÈ´Ù. °úµµÇÑ Á¶Àý ¹× ´« ¸ðÀ½, ½Ã½Å°æ À¯µÎÀÇ ºÎÁ¾, ³»ºÐºñ ÀÌ»ó, Æí½Ä µîÀÌ ¿øÀÎÀ̶ó°í ÇÏ´Â ÁÖÀåµµ ÀÖÀ¸³ª ºÐ¸íÄ¡ ¾Ê´Ù.
  • malignant oxyphilic adenoma
    ¾Ç¼º È£»ê¼º ¼±Á¾
  • malignant plasma cell
    ¾Ç¼º ÇüÁú ¼¼Æ÷
  • malignant pleomorphic adenoma
    ¾Ç¼º ´ÙÇü¼º ¼±Á¾
  • malignant salivary gland tumor
    ¾Ç¼º Ÿ¾×¼± Á¾¾ç
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
genes, structural, neoplasm DNA sequences that code for RNA and for the proteins required for the enzymatic and structural function of neoplastic cells.
(12 Dec 1998)
mucinous cystic neoplasm of pancreas <radiology> = macrocystic adenoma of pancreas, cystadenoma / cystadenocarcinoma, M:F = 1:9, 40-60 years of age, malignant or pre-malignant, large mass (mean 12 cm), multilocular cysts, thick septations, tail / body in 85% (unlike adenocarcinoma and microcystic adenoma), hypo-/avascular, Differential diagnosis: panc pseudocyst, ** Cf: microcystic adenoma
(12 Dec 1998)
histoid neoplasm Old term for a neoplasm characterised by a cytohistologic pattern that closely resembles the tissue from which the neoplastic cells are derived.
(05 Mar 2000)
neoplasm <oncology, pathology> New and abnormal growth of tissue, which may be benign or cancerous.
(16 Dec 1997)
neoplasm circulating cells Exfoliate neoplastic cells circulating in the blood and associated with metastasizing tumours.
(12 Dec 1998)
neoplasm: gallium imaging <radiology> Useful: Hodgkin disease and histiocytic form of NHL poor sensitivity below the diaphragm, Burkitt lymphoma: almost 100% sensitivity, hepatoma: 90% sensitivity, melanoma: 90% sensitivity, leukaemia possibly useful: NHL: good for large and mediastinal lesions, nodal metastases from seminoma and embryonal cell carcinoma: 87% sensitivity, non-small cell lung CA: 85% sensitive not useful: head and neck, GI (especially adenocarcinoma), breast, gynaecological, kiddie tumours see: gallium: indications
(12 Dec 1998)
neoplasm invasiveness Ability of neoplasms to infiltrate and actively destroy surrounding tissue.
(12 Dec 1998)
neoplasm metastasis The transfer of a neoplasm from one organ or part of the body to another remote from the primary site. The ability to metastasize is characteristic of all malignant neoplasms.
(12 Dec 1998)
neoplasm recurrence, local The local recurrence of a neoplasm following treatment. It arises from microscopic cells of the original neoplasm that have escaped therapeutic intervention and later become clinically visible at the original site.
(12 Dec 1998)
neoplasm regression, spontaneous Disappearance of a neoplasm or neoplastic state without the intervention of therapy.
(12 Dec 1998)
neoplasm, residual Remnant of a tumour or cancer after primary, potentially curative therapy. (dr. Daniel masys, written communication)
(12 Dec 1998)
neoplasm seeding The local implantation of tumour cells by contamination of instruments and surgical equipment during and after surgical resection, resulting in local growth of the cells and tumour formation.
(12 Dec 1998)
neoplasm staging Methods which attempt to express in replicable terms the extent of the neoplasm in the patient.
(12 Dec 1998)
neoplasm transplantation Experimental transplantation of neoplasms in laboratory animals for research purposes.
(12 Dec 1998)
DNA, neoplasm DNA present in neoplastic tissue.
(12 Dec 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 7 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • secondary
    µÑ°ÀÇ;ÁßµîÀÇ;º¸Á¶ÀÚ;´ë¸®ÀÚ
  • secondary accent
    Á¦ 2¾×¼¾Æ®
  • secondary ballot
    °á¼± ÅõÇ¥
  • secondary base
    2·ç
  • secondary education
    Áßµî ±³À°
  • secondary industry
    Á¦ 2Â÷ »ê¾÷
  • secondary school
    Áßµî Çб³
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á